StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3077% above fair value
$60.02−1.70 (-2.75%)

Close on Nov 16, 2026Market cap $2.06BP/E 40.8Yield –

Ingevity total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Ingevity's total debt was $1.20B at Jun 30, 2026. For fiscal 2025 it was $1.21B, down 13.7% from the year before. Over ten years it grew 29.7% a year on average. The highest annual figure on record is $1.47B in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.21B-13.7%
FY2024Dec 31, 2024$1.40B-4.5%
FY2023Dec 31, 2023$1.47B-0.4%
FY2022Dec 31, 2022$1.47B+16.1%
FY2021Dec 31, 2021$1.27B-1.8%
FY2020Dec 31, 2020$1.29B+3.4%
FY2019Dec 31, 2019$1.25B+66.3%
FY2018Dec 31, 2018$752.40M+65.9%
FY2017Dec 31, 2017$453.40M-7.2%
FY2016Dec 31, 2016$488.80M+446.8%
FY2015Dec 31, 2015$89.40M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.20B-9.8%
Q1 FY2026Mar 31, 2026$1.20B-13.5%
Q4 FY2025Dec 31, 2025$1.21B-13.7%
Q3 FY2025Sep 30, 2025$1.26B-15.9%
Q2 FY2025Jun 30, 2025$1.33B-11.5%
Q1 FY2025Mar 31, 2025$1.39B-6.7%
Q4 FY2024Dec 31, 2024$1.40B-4.5%
Q3 FY2024Sep 30, 2024$1.50B+1.7%
Q2 FY2024Jun 30, 2024$1.50B-1.5%
Q1 FY2024Mar 31, 2024$1.49B-0.7%
Q4 FY2023Dec 31, 2023$1.47B-0.4%
Q3 FY2023Sep 30, 2023$1.47B+27.6%
Q2 FY2023Jun 30, 2023$1.53B+29.7%
Q1 FY2023Mar 31, 2023$1.50B+18.8%
Q4 FY2022Dec 31, 2022$1.47B+16.1%
Q3 FY2022Sep 30, 2022$1.15B-9.4%
Q2 FY2022Jun 30, 2022$1.18B-7.9%
Q1 FY2022Mar 31, 2022$1.27B-1.4%
Q4 FY2021Dec 31, 2021$1.27B-1.8%
Q3 FY2021Sep 30, 2021$1.27B-2.0%
Q2 FY2021Jun 30, 2021$1.28B-3.9%
Q1 FY2021Mar 31, 2021$1.28B-13.9%
Q4 FY2020Dec 31, 2020$1.29B+3.4%
Q3 FY2020Sep 30, 2020$1.30B-1.3%
Q2 FY2020Jun 30, 2020$1.33B-4.0%
Q1 FY2020Mar 31, 2020$1.49B+4.8%
Q4 FY2019Dec 31, 2019$1.25B+66.3%
Q3 FY2019Sep 30, 2019$1.32B+75.9%
Q2 FY2019Jun 30, 2019$1.39B+85.2%
Q1 FY2019Mar 31, 2019$1.42B+90.0%
Q4 FY2018Dec 31, 2018$752.40M+65.9%
Q3 FY2018Sep 30, 2018$748.90M+65.2%
Q2 FY2018Jun 30, 2018$748.30M+56.4%
Q1 FY2018Mar 31, 2018$748.00M+49.0%
Q4 FY2017Dec 31, 2017$453.40M-7.2%
Q3 FY2017Sep 30, 2017$453.40M-12.6%
Q2 FY2017Jun 30, 2017$478.50M–
Q1 FY2017Mar 31, 2017$502.10M–
Q4 FY2016Dec 31, 2016$488.80M–
Q3 FY2016Sep 30, 2016$518.50M–

More Ingevity figures

See a number that looks wrong?